Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: The St. Carlos gestationaldiabetes study

Diabetes Care

Volumn 37, Issue 9, 2014, Pages 2442-2450

  Duran, Alejandra ^a   Śaenz, Sof́ia ^a   Torrej́on, Maŕia J ^b   Bordí U, Elena ^a   Del Valle, Laura ^a   Galindo, Mercedes ^a   Perez, Noelia ^b   Herraiz, Miguel A ^a,b   Izquierdo, Nuria ^b   Rubio, Miguel A ^a   Runkle, Isabelle ^a   Ṕerez Ferre, Natalia ^a   Cusihuallpa, Idalia ^a   Jiḿenez, Sandra ^a   De La Torre, Nuria Garćia ^a   Ferńandez, Maŕia D ^a   Montañez, Carmen ^a   Familiar, Cristina ^a   Calle Pascual, Alfonso L ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; APGAR SCORE; CARPENTER COUSTAN CRITERIA; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL ASSOCIATION OF THE DIABETES AND PREGNANCY STUDY GROUP CRITERIA; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATHEMATICAL PARAMETERS; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURITY; PREVALENCE; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCREENING; SMALL FOR DATE INFANT; DIABETES, GESTATIONAL; ECONOMICS; GESTATIONAL AGE; HYPERTENSION, PREGNANCY-INDUCED; MASS SCREENING; RISK FACTOR;

ADULT; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MASS SCREENING; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84906675767     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0179     Document Type: Review

References (30)

1. Guariguata L, Linnnenkamp U, Beagley J, Whiting DR, Cho NH. Global estimates of the prevalence of hyperglycaemia in pregnancy for 2013 for the IDF diabetes atlas. Diab Res Clin Pract 2014;103:137-149
2. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013. Obstet Gynecol 2013;122:358-369
3. American Diabetes Association. Executive summary: standards of medical care in diabetesd2011. Diabetes Care 2011;34 (Suppl. 1):S4-S10
4. McCance DR. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab 2011;25:945-958
5. Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002
6. Metzger BE, Gabbe SG, Persson B, et al.; International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676-682
7. Blumer I, Hadar E, Hadden DR, et al. Diabetes and pregnancy: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4227-4249
8. Waugh N, Pearson D, Royle P. Screening for hyperglycaemia in pregnancy: Consensus and controversy. Best Pract Res Clin Endocrinol Metab 2010;24:553-571
9. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013;122:406-416
10. Sacks DA, Hadden DR, Maresh M, et al.; HAPO Study Cooperative Research Group. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012;35:526-528
11. O'Sullivan EP, Avalos G, O'Reilly M, Dennedy MC, Gaffney G, Dunne F; Atlantic DIP collaborators. Atlantic Diabetes in Pregnancy (DIP): The prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 2011;54:1670-1675
12. Benhalima K, Hanssens M, Devlieger R, Verhaeghe J, Mathieu C. Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the Carpenter and Coustan criteria in an area with a low prevalence of gestational diabetes. Int J Endocrinol. 10 January 2013 [Epub ahead of print]
13. Bodmer-Roy S, Morin L, Cousineau J, Rey E. Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes and Pregnancy Study Groups criteria. Obstet Gynecol 2012;120:746-752
14. Avalos GE, Owens LA, Dunne F; ATLANTIC DIP Collaborators. Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 2013;36:3040-3044
15. Ṕerez-Ferre N, Galindo M, Ferńandez MD, et al. The outcomes of gestational diabetes mellitus after a telecare approach are not inferior to traditional outpatient clinic visits. Int J Endocrinol 2010;2010:386941
16. Registro de altas hospitalarias del sistema nacional de salud CMBD (Conjunto ḿinimo b ́asico de datos) (Internet), 2012. Madrid, Spain, Ministerios de Sanidad, servicios sociales e igualdad. Available from http://www.msc.es/estadestudios/estadisticas/cmbd.hmt [in Spanish]. Accessed 20 December 2013
17. Manual de descripcion de los Grupos Relacionados por el Diagnostico Vitoria: Osakidetza/Servicio Vasco de Salud (Internet), 2012. Available at http://osakidetza.euskadi.net [in Spanish]. Accessed 20 December 2013
18. Chevalier N, F́enichel P, Giaume V, et al. Universal two-step screening strategy for gestational diabetes has weak relevance in French Mediterranean women: should we simplify the screening strategy for gestational diabetes in France? Diabetes Metab 2011;37:419-425
19. Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ. Isolated hyperglycemia at 1 hour on oral glucose tolerance test in pregnancy resembles gestational diabetes mellitus in predicting postpartum metabolic dysfunction. Diabetes Care 2008;31:1275-1281
20. Ferrara A, Weiss NS, Hedderson MM, et al. Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 2007;50:298-306
21. Coustan DR. Pregnancy outcomes in women with and without gestational diabetes mellitus according to the International Association of the Diabetes and Pregnancy Study Groups criteria. Obstet Gynecol 2013; 121:377
22. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2486
23. Landon MB, Spong CY, Thom E, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361: 1339-1348
24. Han S, Crowther CA, Middleton P. Intervention for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria. Cochrane Database Syst Rev 2012;1:CD009037
25. Agarwal MM, Dhatt GS, Shah SM. Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 2010;33:2018-2020
26. Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia 2012;55:88-93
27. Marcuello C, Calle-Pascual AL, Fuentes M, et al. Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: The di@bet.es study. Acta Diabetol 2013;50:615-623
28. Ortega E, Franch J, Castell C, et al. Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: The Di@bet.es Study. Ann Nutr Metab 2013;62:339-346
29. Oliva J, Lobo F, Molina B, Monereo S. Direct health care costs of diabetic patients in Spain. Diabetes Care 2004;27:2616-2621
30. Crespo C, Brosa M, Soria-Juan A, et al. Costes directos de la diabetes mellitus y de suscomplicaciones en España (Estudio SECCAID: Spain estimated cost Ciberdem-Cabimer in Diabetes). Av Diabetol 2013;29:182-189